Trials / Unknown
UnknownNCT06028256
Norepinephrine Prevent Post-induction Hypotension in High-risk Patients
Continuous Norepinephrine Infusion Before General Anesthesia to Prevent Post-induction Hypotension in High-risk Patients Undergoing Major Noncardiac Surgery
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- First Affiliated Hospital of Kunming Medical University · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The investigators aimed to investigate the effects of continuous infusion of norepinephrine before and after general anesthesia induction on the occurrence of post-induction hypotension.
Detailed description
Intraoperative hypotension is common after general anesthesia induction and is associated with adverse postoperative events. Norepinephrine is one of the most applied vasopressors in clinical to treat intraoperative hypotension. Due to the absence of effective measures for predicting intraoperative hypotension, infusing norepinephrine before and during anesthesia induction may reduce intraoperative hypotension. There is currently a lack of research regarding whether continuous norepinephrine infusion before and during the induction of general anesthesia can mitigate or prevent post-induction hypotension. The investigators aim to investigate the effects of continuous infusion of norepinephrine before and after general anesthesia induction on the occurrence of post-induction hypotension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norepinephrine Hydrochloride | Both arms of patients will receive standard anesthesia and surgical management. Radial artery cannulation and invasive blood pressure monitoring will be perform. Norepinephrine will be pumped at a rate of 10 ml/h for 5 minutes before anesthesia induction to skin incision. |
| DRUG | Placebo | Normal saline will be pumped at a rate of 10 ml/h for 5 minutes before anesthesia induction to skin incision. |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2024-04-01
- Completion
- 2024-10-01
- First posted
- 2023-09-08
- Last updated
- 2023-09-08
Source: ClinicalTrials.gov record NCT06028256. Inclusion in this directory is not an endorsement.